Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century. [PDF]
Bender DA +33 more
europepmc +1 more source
OctoChemDB: An Aggregated Database for Small Molecule Identification Using High-Resolution MS Data. [PDF]
Silvestre R +6 more
europepmc +1 more source
Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety. [PDF]
Żełabowski K +11 more
europepmc +1 more source
Bioanalysis of amphetamines in alternative matrices using a sensitive and validated liquid chromatography-tandem mass spectrometry method and its application to real samples. [PDF]
Makhdoom HS, Abid AI, Khan NUH, Abbas Z.
europepmc +1 more source
Trends in urine screening positive for cannabis of emergency department admissions in Israel 2016-2024. [PDF]
Miron O +4 more
europepmc +1 more source
Related searches:
3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) is a synthetic amphetamine analogue that is recreationally used to obtain a psychological effect of enhanced affiliative emotional response. Its use in Western countries appears to be increasing, particularly among young individuals.Pertinent basic and clinical literature is critically reviewed.A ...
Rif S, El-Mallakh, Henry David, Abraham
openaire +2 more sources
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire +1 more source
MDMA and MDMA-Assisted Therapy
American Journal of PsychiatryMDMA (i.e., 3,4-methylenedixoymethamphetamine), commonly known as "Ecstasy" or "Molly," has been used since the 1970s both in recreational and therapeutic settings. The Food and Drug Administration (FDA) designated MDMA-Assisted Therapy (MDMA-AT) as a Breakthrough Therapy for posttraumatic stress disorder (PTSD) in 2017, and the FDA is requiring an ...
Aaron S, Wolfgang +9 more
openaire +2 more sources
Classic psychedelics, including psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine, and mescaline, and entactogens/empathogens, especially 3,4-methylenedioxymethamphetamine, have received renewed attention in psychiatric research and may be developed into medications for such indications as anxiety, depression, cluster headache, and ...
Liechti, Matthias E., Holze, Friederike
openaire +3 more sources
Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Pediatric Emergency Care, 2000Ecstasy (MDMA) is an amphetamine derivative of growing popularity. The drug produces a range of toxicities when taken either in standard doses or overdose. In overdose it has major toxicity, producing several different life-threatening manifestations. Hepatotoxicity and hyponatremia are common but poorly understood consequences of MDMA overdose.
openaire +2 more sources

